Wachtell, Lipton, Rosen & Katz represented Bausch + Lomb in the transaction. Davis Polk & Wardwell advised on legal matters relating to the financing. Bausch +...
Bausch + Lomb’s Acquisition of XIIDRA from Novartis
Bausch + Lomb’s $630 Million Initial Public Offering
Davis Polk advised Bausch Health Companies Inc. in connection with the separation of its eye health business into a new publicly traded company, Bausch + Lomb...
Bausch + Lomb’s Agreement With Carl C. Icahn
Wachtell, Lipton, Rosen & Katz represented Bausch + Lomb. Bausch + Lomb Corporation entered into an agreement with Carl C. Icahn relating to the composition of...